Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (561-570 of 633) with videos related to

Pageof 64
Sort By:
Cancer Research|March 16, 2011
Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistanceZhi Shi, Amit K Tiwari, Suneet Shukla, et al.
International Heart Journal|July 21, 2020
MiR-182-5p Inhibits the Proliferation of Vascular Smooth Muscle Cells Induced by ox-LDL Through Targeting PAPPAChaolong Jin, Shan Gao, Dayuan Li, et al.
Cancer Research|May 18, 2011
Contribution of Abcc10 (Mrp7) to in vivo paclitaxel resistance as assessed in Abcc10(-/-) miceElizabeth A Hopper-Borge, Timothy Churchill, Chelsy Paulose, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 12, 2025
HSP70 Interactome-Mediated Proteolysis Targeting Chimera (HSP70-PROTAC) for Ferroptosis-Driven Cancer TreatmentJinyun Dong, Yulong Li, Hui Liang, et al.
European Journal of Medicinal Chemistry|November 12, 2017
Exploration of 1,2,3-triazole-pyrimidine hybrids as potent reversal agents against ABCB1-mediated multidrug resistanceBo Wang, Bing Zhao, Zhe-Sheng Chen, et al.
Cancer Letters|November 6, 2018
Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancerYun-Kai Zhang, Yi-Jun Wang, Zi-Ning Lei, et al.
Molecular Pharmaceutics|October 11, 2012
BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivoDong-Mei Zhang, Chang Shu, Jun-Jiang Chen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 24, 2022
CCT251545 enhances drug delivery and potentiates chemotherapy in multidrug-resistant cancers by Rac1-mediated macropinocytosisSiyuan Qin, Zhe Zhang, Zhao Huang, et al.
Biochemical Pharmacology|January 20, 2009
Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistanceYing Zhou, Elizabeth Hopper-Borge, Tong Shen, et al.
Biochemical Pharmacology|December 9, 2008
Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478Zhi Shi, Amit K Tiwari, Suneet Shukla, et al.
Pageof 64

Showing results (561-570 of 633) with videos related to

Sort By:
Pageof 64
Cancer Research|March 16, 2011
Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistanceZhi Shi, Amit K Tiwari, Suneet Shukla, et al.
International Heart Journal|July 21, 2020
MiR-182-5p Inhibits the Proliferation of Vascular Smooth Muscle Cells Induced by ox-LDL Through Targeting PAPPAChaolong Jin, Shan Gao, Dayuan Li, et al.
Cancer Research|May 18, 2011
Contribution of Abcc10 (Mrp7) to in vivo paclitaxel resistance as assessed in Abcc10(-/-) miceElizabeth A Hopper-Borge, Timothy Churchill, Chelsy Paulose, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 12, 2025
HSP70 Interactome-Mediated Proteolysis Targeting Chimera (HSP70-PROTAC) for Ferroptosis-Driven Cancer TreatmentJinyun Dong, Yulong Li, Hui Liang, et al.
European Journal of Medicinal Chemistry|November 12, 2017
Exploration of 1,2,3-triazole-pyrimidine hybrids as potent reversal agents against ABCB1-mediated multidrug resistanceBo Wang, Bing Zhao, Zhe-Sheng Chen, et al.
Cancer Letters|November 6, 2018
Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancerYun-Kai Zhang, Yi-Jun Wang, Zi-Ning Lei, et al.
Molecular Pharmaceutics|October 11, 2012
BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivoDong-Mei Zhang, Chang Shu, Jun-Jiang Chen, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 24, 2022
CCT251545 enhances drug delivery and potentiates chemotherapy in multidrug-resistant cancers by Rac1-mediated macropinocytosisSiyuan Qin, Zhe Zhang, Zhao Huang, et al.
Biochemical Pharmacology|January 20, 2009
Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistanceYing Zhou, Elizabeth Hopper-Borge, Tong Shen, et al.
Biochemical Pharmacology|December 9, 2008
Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478Zhi Shi, Amit K Tiwari, Suneet Shukla, et al.
Pageof 64